Alzheimer’s Disease Risk Prediction Tool is Cost-Effective
A recent modelling study by ESiOR Oy and VTT Technical Research Centre of Finland assessed the cost-effectiveness of a machine learning-based risk prediction tool for
12.2.2025
ESiOR Oy – Creating Insights
Expert solutions to the challenges of healthcare organisations, pharmaceutical companies, and health businesses.
Expertise, research, consultation, and tools for better healthcare decisions.
Years of experience, profound insight, and remarkable results in the field.
Why ESiOR?
Better decisions – higher value for money – the best effectiveness
It pays off to work with ESiOR! We are curious, professional, and reliable. We love challenges. We provide expert solutions for value demonstration of healthcare products, services, and processes, as well as expertise to improve effectiveness and cost-effectiveness in healthcare.
Our most important task is to help our customers understand, communicate, and benefit from the information composed of versatile data. Improving knowledge and achieving our customers’ objectives is the best reward for us.
The most essential outcome of our work is effective, high-quality care for people.
SHEOR
Our SHEOR services assess the effectiveness and cost-effectiveness of medicinal products, treatments, and services.
DSEG
Our DSEG services compile, generate, demonstrate, and communicate treatment value and competitive advantage innovatively.
From data to competitive advantage™ - data, analysis, knowledge management, and communication
Our Vision
Together, we can help create a society that provides more health and well-being based on scientific evidence. Today’s decisions shape the future.
Latest articles and news
Read our blog posts and news.
The Societal Value of Clinical Drug Trials in Finland: 10 Million Euros per Trial
The Societal Value of Clinical Drug Trials in Finland: 10 Million Euros per Trial A study by ESiOR Oy and
6.2.2025
Pulmonary Hypertension in Finland: Key Findings from the FINPAH Study (2008–2020)
Pulmonary Hypertension in Finland: Key Findings from the FINPAH Study (2008–2020) The FINPAH study offers valuable insights into pulmonary arterial
3.2.2025
Meta-Analysis: Visual Disturbances with Trifocal Intraocular Lenses
A recent meta-analysis published in Ophthalmology and Therapy sheds light on the visual disturbances reported by patients following bilateral implantation
27.1.2025
Interested? Contact us and we will tell you more.
Let our experienced specialists perform the time-consuming application, research, modelling, and development processes. We are here to help you with your challenges, great and small.